← All verdicts
Verdict

Data Unavailable

Every analyzed stock in Data Unavailable — 2,921 companies. Each card shows price, our model's intrinsic value (IV), and how far price sits above or below it. Click any card for the full analysis. This is a research-triage view, not a buy/sell signal.

Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
"Data Unavailable" by: Model value (price vs DCF) Owner-earnings return (equity bond)

This lens: price against our probability-weighted DCF value (P/IV). Its own forward record began accruing on 2026-09-10 (daily snapshots); until a year of it exists, the panel below tests the nearest cousin we can measure point-in-time — cheap on book value — and says so.

Market state today: Calm — the S&P 500 closed 3.1% below its 1-year high (as of 2026-09-16). Our rule, the same one used to split every backtest on this site: sell-off = 10% or more below the 1-year high, borderline from 5%, calm otherwise. A further 7.2% fall from here would put us in a sell-off. Since 2006 the market has been in a sell-off 16.6% of the time, across 13 episodes (red bands).
2007200920112013201520172019202120232025
S&P 500 (SPY, adjusted) distance from its trailing 1-year high, weekly. Amber band: borderline (−5% to −10%). Red band: sell-off (below −10%). The dot is today. History to 2026-08-19 from the research database; today from the live feed.
Backtest · point in time · 8,702 entries in the study

Does this screen work? The record for exactly these filters

Screen tested: Proxy: price-to-book ≤ 1.2 (undervalued band has no point-in-time history yet) · bought the day of the annual report, held 12 months
Probable Buy every company that met this screen on the day it filed its annual report, hold 12 months: on average it beat the S&P 500 by +12.6 pts (1,427 entries, 311 companies, very unlikely to be luck). 50% of entries beat the S&P; 25% beat it by 30 points or more; 30% trailed it by 20 points or more. Owning everything instead averaged +1.7 pts, so the screen's edge is +10.9 pts.
+12.6 ptsvs S&P, average
50%beat the S&P
25%up 30+ pts vs S&P
30%down 20+ pts vs S&P
+14.0 ptsvs small caps, 12 mo
−15.1 pts 2019worst year to buy ?
6.1luck check ?
Does the holding period matter?3 mo: +2.3 pts 49% beat6 mo: +4.6 pts 49% beat12 mo: +12.6 pts 50% beat24 mo: +21.8 pts 46% beat3 yr, per yr: +1.3 pts 40% beat
Market state at entryCompany-yearsvs S&P 12 movs small caps
Calm ◀ today1,245+7.9 pts t 4.6+10.1 pts
Sell-off (S&P ≥10% off high)182+44.5 pts t 4.0+40.7 pts
Sector (SEC group)nvs S&P 12 mo3 yrs / yr
Industrials & manufacturing466+13.0 pts t 4.0−2.2 pts
Energy126+7.4 pts t 1.2−7.8 pts
Other115+8.4 pts t 1.8+3.8 pts
Tech hardware & semis113+10.9 pts t 1.6+2.3 pts
Services96+11.9 pts t 2.7+12.2 pts
Retail & consumer87+17.2 pts t 2.1+10.2 pts
Finance & real estate72−1.7 pts t -0.5−2.4 pts
Utilities65+5.6 pts t 0.6−1.2 pts
Construction53+13.2 pts t 1.7−2.4 pts
Biotech & pharma44+47.1 pts t 1.6+10.0 pts
Telecom & media43+14.0 pts t 0.7−6.3 pts
Software & IT services35+39.9 pts t 1.8+1.2 pts

Holds up out of sample? Before 2018: +10.7 pts (n 629, t 6.0). From 2018: +14.0 pts (n 798, t 4.1). Same sign in both halves.

Year2010201120122013201420152016201720182019202020212022202320242025
vs S&P+13 pts+5 pts+14 pts+18 pts−4 pts−4 pts+22 pts+12 pts−3 pts−15 pts+87 pts+8 pts+17 pts−9 pts−7 pts+15 pts
n254310610178841118178991297276108121115

Read the research behind this screen: Price-to-book still sorts, across all sizes → · Test your own combination in the Screen Lab →

Our model values are recomputed daily but were never stored historically, so this band cannot be backtested honestly yet. Daily snapshots began 2026-09-10; a true record accrues from there. Until then the nearest tested cousin is shown — cheap on book value — and labelled as a proxy. Point-in-time: each entry is one company bought at the first close after its 10-K filing date, using only filings available that day, held 12 months; result = total return minus SPY over the same months (vs IWM for 12 months; 3-yr annualised). Survivorship-tilted universe; no costs; read spreads, not levels. Educational, hypothetical, before costs.

Sort by: A–Z Riskiest Most overvalued Most shorted Buyers' strike Largest
TPST
Tempest Therapeutics, Inc.
Valuation N/A
Healthcare Risk 35 · Moderate
Price$0.81
Model IV—
P/IV—
Limited data — see page
TPVG
TriplePoint Venture Growth BDC Corp.
Valuation N/A
Unknown Risk 67 · High
Price$5.16
Model IV—
P/IV—
Limited data — see page
TRAD
APEX Tech Acquisition Inc.
Valuation N/A
Financial Services Risk 40 · Elevated
Price$10.02
Model IV—
P/IV—
Limited data — see page
TRAX
First Tracks Biotherapeutics, Inc.
Valuation N/A
Healthcare Risk 58 · Elevated
Price$36.44
Model IV—
P/IV—
Limited data — see page
TRDA
Entrada Therapeutics, Inc.
Valuation N/A
Healthcare Risk 46 · Elevated
Price$6.80
Model IV—
P/IV—
Market implies +34.2%/yr vs model +15.0% · above model
TRGS
TRG Latin America Acquisitions Corp.
Valuation N/A
Financial Services
Price$10.03
Model IV—
P/IV—
Limited data — see page
TRGSR
TRG Latin America Acquisitions Corp.
Valuation N/A
Financial Services
Price$0.17
Model IV—
P/IV—
Limited data — see page
TRI
THOMSON REUTERS CORP /CAN/
Valuation N/A
Communication Services Risk 36 · Moderate
Price$97.35
Model IV—
P/IV—
Limited data — see page
TRIB
TRINITY BIOTECH PLC
Valuation N/A
Healthcare Risk 27 · Moderate
Price$7.74
Model IV—
P/IV—
Limited data — see page
TRIN
Trinity Capital Inc.
Valuation N/A
Unknown Risk 48 · Elevated
Price$17.93
Model IV—
P/IV—
Limited data — see page
TRINI
Trinity Capital Inc.
Valuation N/A
Unknown Risk 50 · Elevated
Price$25.39
Model IV—
P/IV—
Limited data — see page
TRINZ
Trinity Capital Inc.
Valuation N/A
Unknown Risk 55 · Elevated
Price$25.43
Model IV—
P/IV—
Limited data — see page
TRMD
TORM plc
Valuation N/A
Industrials Risk 37 · Moderate
Price$35.08
Model IV—
P/IV—
Limited data — see page
TRNR
Interactive Strength, Inc.
Valuation N/A
Technology Risk 33 · Moderate
Price$3.04
Model IV—
P/IV—
Market implies -50.0%/yr vs model +50.0% · below model
TRON
Tron Inc.
Valuation N/A
Financial Services Risk 42 · Elevated
Price$1.41
Model IV—
P/IV—
Market implies +59.8%/yr vs model +2.0% · above model
TROO
Troops, Inc. /Cayman Islands/
Valuation N/A
Financial Services Risk 40 · Elevated
Price$2.09
Model IV—
P/IV—
Market implies +15.8%/yr vs model +46.8% · below model
TRSG
Tungray Technologies Inc
Valuation N/A
Industrials
Price$1.45
Model IV—
P/IV—
Limited data — see page
TRUG
TruGolf Holdings, Inc.
Valuation N/A
Consumer Cyclical Risk 44 · Elevated
Price$0.65
Model IV—
P/IV—
Market implies -50.0%/yr vs model +15.0% · below model
TRVG
trivago N.V.
Valuation N/A
Technology Risk 40 · Elevated
Price$5.62
Model IV—
P/IV—
Limited data — see page
TSEM
TOWER SEMICONDUCTOR LTD
Valuation N/A
Technology Risk 46 · Elevated
Price$211.52
Model IV—
P/IV—
Market implies +56.7%/yr vs model +2.0% · above model
TSHA
Taysha Gene Therapies, Inc.
Valuation N/A
Healthcare Risk 42 · Elevated
Price$5.02
Model IV—
P/IV—
Market implies +83.9%/yr vs model +15.0% · above model
TTI
TETRA TECHNOLOGIES INC
Valuation N/A
Energy Risk 55 · Elevated
Price$6.81
Model IV—
P/IV—
Market implies +28.3%/yr vs model +8.0% · above model
TTMI
TTM TECHNOLOGIES INC
Valuation N/A
Technology Risk 47 · Elevated
Price$112.46
Model IV—
P/IV—
Market implies +25.6%/yr vs model +8.9% · above model
TULP
BLOOMIA HOLDINGS, INC.
Valuation N/A
Basic Materials Risk 49 · Elevated
Price$3.40
Model IV—
P/IV—
Market implies +40.1%/yr vs model +8.0% · above model
TVC
Tennessee Valley Authority
Valuation N/A
Utilities
Price$23.82
Model IV—
P/IV—
Limited data — see page
TVE
Tennessee Valley Authority
Valuation N/A
Utilities
Price$23.34
Model IV—
P/IV—
Limited data — see page
TVRD
Tvardi Therapeutics, Inc.
Valuation N/A
Healthcare Risk 42 · Elevated
Price$1.87
Model IV—
P/IV—
Market implies -1.3%/yr vs model +15.0% · below model
TWAV
TaoWeave, Inc.
Valuation N/A
Technology Risk 28 · Moderate
Price$1.21
Model IV—
P/IV—
Market implies +29.7%/yr vs model +2.0% · above model
TWG
Top Wealth Group Holding Ltd
Valuation N/A
Consumer Defensive Risk 27 · Moderate
Price$0.37
Model IV—
P/IV—
Market implies -50.0%/yr vs model +50.0% · below model
TWLO
TWILIO INC
Valuation N/A
Technology Risk 42 · Elevated
Price$227.35
Model IV—
P/IV—
Market implies +57.8%/yr vs model +16.6% · above model
TWST
Twist Bioscience Corp
Valuation N/A
Healthcare Risk 31 · Moderate
Price$127.22
Model IV—
P/IV—
Market implies +49.9%/yr vs model +29.9% · above model
TXN
TEXAS INSTRUMENTS INC
Valuation N/A
Technology Risk 43 · Elevated
Price$263.42
Model IV—
P/IV—
Market implies +25.7%/yr vs model +2.0% · above model
TYGO
TIGO ENERGY, INC.
Valuation N/A
Technology Risk 31 · Moderate
Price$1.03
Model IV—
P/IV—
Market implies -50.0%/yr vs model +15.0% · below model
UAMY
UNITED STATES ANTIMONY CORP
Valuation N/A
Basic Materials Risk 27 · Moderate
Price$4.87
Model IV—
P/IV—
Market implies +69.3%/yr vs model +8.0% · above model
UAVS
AgEagle Aerial Systems Inc.
Valuation N/A
Industrials Risk 31 · Moderate
Price$0.97
Model IV—
P/IV—
Market implies +19.9%/yr vs model +7.0% · above model
UCL
uCloudlink Group Inc.
Valuation N/A
Communication Services Risk 32 · Moderate
Price$0.43
Model IV—
P/IV—
Market implies +18.4%/yr vs model +4.1% · above model
UEC
URANIUM ENERGY CORP
Valuation N/A
Basic Materials Risk 54 · Elevated
Price$10.45
Model IV—
P/IV—
Market implies +83.3%/yr vs model +8.0% · above model
UGA
United States Gasoline Fund, LP
Valuation N/A
Financial Services Risk 40 · Elevated
Price$138.70
Model IV—
P/IV—
Limited data — see page
UHAL
U-Haul Holding Co /NV/
Valuation N/A
Industrials Risk 48 · Elevated
Price$64.05
Model IV—
P/IV—
Market implies +64.6%/yr vs model +2.2% · above model
UK
Ucommune International Ltd
Valuation N/A
Technology Risk 39 · Moderate
Price$2.00
Model IV—
P/IV—
Market implies +14.1%/yr vs model +2.0% · above model
ULCC
Frontier Group Holdings, Inc.
Valuation N/A
Industrials Risk 31 · Moderate
Price$5.57
Model IV—
P/IV—
Market implies +71.4%/yr vs model +8.0% · above model
UMAC
Unusual Machines, Inc.
Valuation N/A
Technology Risk 42 · Elevated
Price$23.03
Model IV—
P/IV—
Market implies +75.1%/yr vs model +15.0% · above model
UNCY
Unicycive Therapeutics, Inc.
Valuation N/A
Healthcare Risk 46 · Elevated
Price$4.71
Model IV—
P/IV—
Market implies +62.3%/yr vs model +15.0% · above model
UNL
United States 12 Month Natural Gas Fund, LP
Valuation N/A
Financial Services Risk 38 · Moderate
Price$5.82
Model IV—
P/IV—
Limited data — see page
UONEK
URBAN ONE, INC.
Valuation N/A
Communication Services Risk 62 · High
Price$4.09
Model IV—
P/IV—
Market implies -50.0%/yr vs model +2.0% · below model
UP
Wheels Up Experience Inc.
Valuation N/A
Industrials Risk 57 · Elevated
Price$3.29
Model IV—
P/IV—
Market implies +27.9%/yr vs model +2.0% · above model
UPB
Upstream Bio, Inc.
Valuation N/A
Healthcare Risk 36 · Moderate
Price$5.73
Model IV—
P/IV—
Market implies +66.4%/yr vs model +9.5% · above model
UPST
Upstart Holdings, Inc.
Valuation N/A
Financial Services Risk 35 · Moderate
Price$25.59
Model IV—
P/IV—
Market implies +76.9%/yr vs model +5.3% · above model
UPXI
UPEXI, INC.
Valuation N/A
Financial Services Risk 31 · Moderate
Price$1.04
Model IV—
P/IV—
Market implies +1.6%/yr vs model +2.0% · in line
URG
UR-ENERGY INC
Valuation N/A
Basic Materials Risk 38 · Moderate
Price$1.29
Model IV—
P/IV—
Market implies +40.8%/yr vs model +5.0% · above model
URGN
UroGen Pharma Ltd.
Valuation N/A
Healthcare Risk 60 · High
Price$42.31
Model IV—
P/IV—
Market implies +37.7%/yr vs model +23.0% · above model
USAR
USA Rare Earth, Inc.
Valuation N/A
Basic Materials Risk 30 · Moderate
Price$15.56
Model IV—
P/IV—
Market implies +91.2%/yr vs model +5.0% · above model
USBC
USBC, Inc.
Valuation N/A
Financial Services Risk 34 · Moderate
Price$0.49
Model IV—
P/IV—
Market implies +35.7%/yr vs model +15.0% · above model
USCI
United States Commodity Index Funds Trust
Valuation N/A
Financial Services Risk 46 · Elevated
Price$110.44
Model IV—
P/IV—
Limited data — see page
USEA
United Maritime Corp
Valuation N/A
Industrials Risk 44 · Elevated
Price$2.99
Model IV—
P/IV—
Market implies +10.7%/yr vs model -10.0% · above model
USIO
Usio, Inc.
Valuation N/A
Financial Services Risk 40 · Elevated
Price$2.37
Model IV—
P/IV—
Limited data — see page
USL
United States 12 Month Oil Fund, LP
Valuation N/A
Financial Services Risk 32 · Moderate
Price$56.11
Model IV—
P/IV—
Limited data — see page
UUUU
ENERGY FUELS INC
Valuation N/A
Basic Materials Risk 55 · Elevated
Price$12.95
Model IV—
P/IV—
Market implies +87.0%/yr vs model +5.0% · above model
UWMC
UWM Holdings Corp
Valuation N/A
Financial Services Risk 40 · Elevated
Price$1.35
Model IV—
P/IV—
Market implies +20.5%/yr vs model +2.0% · above model
UXIN
Uxin Ltd
Valuation N/A
Technology Risk 32 · Moderate
Price$1.11
Model IV—
P/IV—
Market implies +41.0%/yr vs model +46.6% · below model